Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

AT&T Shows No Sign of Slowing Down
AT&T Shows No Sign of Slowing Down

While fellow telecom giant Verizon is struggling with subscriber losses, AT&T (NYSE: T) put up strong numbers in its first-quarter report Wednesday morning. Postpaid phone net adds topped 300,000

Why AT&T Stock Lagged the Market Today
Why AT&T Stock Lagged the Market Today

The stock market was in rally mode on Wednesday, but you wouldn't know it from AT&T's (NYSE: T) performance. Investors reacted to the company's latest set of quarterly earnings but traded the stock

Why Summit Therapeutics Rocketed Double-Digits Today
Why Summit Therapeutics Rocketed Double-Digits Today

Shares of lung cancer biotech Summit Therapeutics (NASDAQ: SMMT) rocketed 14.7% on Wednesday as of 1:45 p.m. ET.

The markets were broadly up today on a potential easing of trade tensions with China

Tempus AI Is Skyrocketing Today -- Is the Stock a Buy Right Now?
Tempus AI Is Skyrocketing Today -- Is the Stock a Buy Right Now?

Amid a bullish backdrop for the broader market, Tempus AI (NASDAQ: TEM) stock is posting big gains Wednesday. The company's share price was up 15.8% as of 1:45 p.m. ET. At the same point in time

Why Tempus AI Stock Is Skyrocketing Today
Why Tempus AI Stock Is Skyrocketing Today

Shares of Tempus AI (NASDAQ: TEM) were skyrocketing 16.5% higher as of 10:39 a.m. ET on Wednesday. The big gain came after the healthcare artificial intelligence (AI) company announced a multiyear

AT&T Surpasses Q1 Revenue Estimates
AT&T Surpasses Q1 Revenue Estimates

Telecommunications giant AT&T (NYSE:T) reported fiscal 2025 first quarter earnings on Wednesday, April 23, that matched or exceeded analysts' consensus expectations. Revenue of $30.63 billion came

This Company's Co-CEOs Just Bought More Shares. Should You?
This Company's Co-CEOs Just Bought More Shares. Should You?

Nobody has more information about a company than its insiders, especially its executive management team. That's why when one of them buys more shares, it sometimes gives individual investors

Better Artificial Intelligence Stock: AT&T vs. SoundHound AI
Better Artificial Intelligence Stock: AT&T vs. SoundHound AI

Technology routinely affects nearly every part of the economy. In other words, companies that aren't traditional technology stocks can benefit from artificial intelligence (AI).

U.S

2 Dividend Stocks to Double Up on Right Now
2 Dividend Stocks to Double Up on Right Now

Dividend stocks are the best antidote for market volatility. There's nothing like seeing quarterly cash deposits in your account from industry-leading businesses. With the S&P 500 (SNPINDEX: ^GSPC)

Aswath Damodaran on Investing in Uncertainty
Aswath Damodaran on Investing in Uncertainty

Aswath Damodaran teaches corporate finance and valuation at the Stern School of Business at New York University. In this podcast, Motley Fool Senior Analyst Matt Argersinger caught up with Damodaran

Is AT&T Stock a Buy Now?
Is AT&T Stock a Buy Now?

There's a lot of uncertainty in the stock market and the U.S. economy right now, and that's probably putting it lightly. As the Trump administration implements new tariffs, businesses and consumers

3 Top Stocks to Buy and Hold for 20 Years
3 Top Stocks to Buy and Hold for 20 Years

As the stock market swings wildly thanks to erratic, unpredictable, and potentially economically damaging tariff policies from the Trump administration, predicting anything in the near term about

Why Summit Therapeutics Rallied Double Digits Today on Another Down day for the Markets
Why Summit Therapeutics Rallied Double Digits Today on Another Down day for the Markets

Shares of lung cancer-focused biotech Summit Therapeutics (NASDAQ: SMMT) rallied 16.6% at its highs of the day before settling into a 10.4% gain on Thursday as of 3:54 p.m. EDT, even though the

3 No-Brainer Growth Stocks to Buy for Less Than $100
3 No-Brainer Growth Stocks to Buy for Less Than $100

Don't let the sell-off in the markets scare you off: Now may be an ideal time to buy stocks. Even if you don't have a lot of money that you can afford to invest, there are many great stocks you can

1 Safe Stock to Buy as Tariffs Trigger Market Crash
1 Safe Stock to Buy as Tariffs Trigger Market Crash

There's no such thing as a completely "safe" stock, but some stocks are less risky than others. That's particularly true during times of extreme uncertainty and volatility. The major stock indices

2 Stocks That Have More Than Doubled in the Past Year to Buy and Hold for a Decade
2 Stocks That Have More Than Doubled in the Past Year to Buy and Hold for a Decade

Equity markets recently dipped due to concerns of deteriorating macroeconomic conditions, with the latest trigger being President Trump's trade wars. The S&P 500 index's performance over the

Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday
Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday

As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on Wednesday decimated the stock market on Thursday. It had one of its worst

3 Growth Stocks That Have Dwarfed Nvidia's Returns Over the Past 12 Months
3 Growth Stocks That Have Dwarfed Nvidia's Returns Over the Past 12 Months

Is the excitement surrounding chipmaker Nvidia fading? As of Monday, shares of the tech giant were down 19% since the start of 2025. Whether that's due to its high valuation, concerns about the

Is AT&T Stock a Buy?
Is AT&T Stock a Buy?

AT&T (NYSE: T) is often considered a slow-growth stock -- the kind of investment people hold for stable returns and dividends rather than market-beating gains. But over the past 12 months, the

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today
Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today

Shares of biotechnology stocks such as Recursion Pharmaceuticals (NASDAQ: RXRX), Summit Therapeutics (NASDAQ: SMMT), and CRISPR Therapeutics AG (NASDAQ: CRSP) plunged on Monday, down 9.4%, 5.6%, and

Where Will AT&T Stock Be in 1 Year?
Where Will AT&T Stock Be in 1 Year?

AT&T (NYSE: T) shareholders have plenty to celebrate, with the stock up 24% thus far in 2025. The telecommunications giant has presented robust earnings, reinforcing an optimistic long-term outlook

Here's How Many Shares of AT&T You Should Own to Get $1,000 in Yearly Dividends
Here's How Many Shares of AT&T You Should Own to Get $1,000 in Yearly Dividends

Dividend-paying stocks are hard to beat for income. If you're retired, you can use that money for your living expenses, and if you're still far from retirement, you might simply reinvest those

Is AT&T a Buy?
Is AT&T a Buy?

U.S. telecommunications giant AT&T (NYSE: T) has lulled investors to sleep with its poor performance over most of the past decade. But the stock has enjoyed a face-ripping rally over the past year

Better Telecom Stock: AT&T vs. T-Mobile
Better Telecom Stock: AT&T vs. T-Mobile

Uncertainty over the future of the U.S. economy has roiled the stock market, causing many stocks to sink. In this environment, telecom stocks present a potential reprieve. Society's dependence on

Why Summit Therapeutics Stock Slipped Today
Why Summit Therapeutics Stock Slipped Today

Summit Therapeutics (NASDAQ: SMMT) stock did better than a lot of other equities during an otherwise forgettable trading session on Wednesday. In contrast to other titles that fell notably, Summit